Fresenius Medical Care AG & Co. KGaA

  • WKN: 578580
  • ISIN: DE0005785802
  • Land: Deutschland

Nachricht vom 10.04.2012 | 19:54

Fresenius Medical Care AG & Co. KGaA: Publication according to § 26 paragraph. 1 WpHG with the objective of Europe-wide distribution


Fresenius Medical Care AG & Co. KGaA 

10.04.2012 19:54

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------


Notification of voting rights pursuant to sec. 41 para. 4d WpHG
We received the following notification pursuant to sec. 41 para. 4d WpHG on
April 04, 2012:

1. Listed company:
Fresenius Medical Care AG & Co. KGaA
Else-Kröner-Straße 1, 61352 Bad Homburg, Deutschland

2. Notifier:
Société Générale SA, Paris, France 

3. Total amount of voting rights held on February 1st, 2012:
5,50% (equals 16524820 voting rights)
calculated from the following total number of voting rights issued:
300178811

4. Detailed information on the voting rights proportion:

Voting rights proportion based on financial/other instruments pursuant to
sec. 25a WpHG:
5.50% (equals 16524820 voting rights)

thereof held indirectly:
2.74% (equals 8228220 voting rights)

Voting rights proportion based on financial/other instruments pursuant to
sec. 25 WpHG:
0% (equals 0 voting rights)

thereof held indirectly:
0% (equals 0 voting rights)

Voting rights pursuant to sec. 21, 22 WpHG:
0% (equals 0 voting rights)

5. Detailed information on financial/other instruments pursuant to sec. 25a
WpHG:

Chain of controlled undertakings:
Société Générale Effekten GmbH, Neue Mainzer Straße 36, 60325 Frankfurt

ISIN or name/description of the financial/other instrument: Listed call
DE000SG3Y6C5
Maturity: 03.01.2025
Expiration date: 

ISIN or name/description of the financial/other instrument: Listed call
DE000SG6D8Z4
Maturity: 03.01.2025
Expiration date: 

ISIN or name/description of the financial/other instrument: Listed call
DE000SG12GQ2
Maturity: 18.12.2015
Expiration date: 

ISIN or name/description of the financial/other instrument: Listed call
DE000SG12GR0
Maturity: 18.12.2015
Expiration date: 

ISIN or name/description of the financial/other instrument: Listed call
DE000SG2AkG3
Maturity: 18.12.2015
Expiration date: 

ISIN or name/description of the financial/other instrument: Listed call
DE000SG2LWP6
Maturity: 16.12.2016
Expiration date: 

ISIN or name/description of the financial/other instrument: Listed call
DE000SG2LWQ4
Maturity: 16.12.2016
Expiration date: 

ISIN or name/description of the financial/other instrument: Listed call
DE000SG2LWR2
Maturity: 16.12.2016
Expiration date: 

ISIN or name/description of the financial/other instrument: Future
DE000A0QZA54
Maturity: 16.03.2025
Expiration date: 

ISIN or name/description of the financial/other instrument: Structured call
option
Maturity: 03.01.2025
Expiration date: 

ISIN or name/description of the financial/other instrument: Structured call
option
Maturity: 18.12.2015
Expiration date: 

ISIN or name/description of the financial/other instrument: Structured call
option
Maturity: 16.12.2016
Expiration date: 

ISIN or name/description of the financial/other instrument: Listed call
DE00005785802
Maturity: 15.06.2012
Expiration date: 



10.04.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      Fresenius Medical Care AG & Co. KGaA
              Else-Kröner-Straße 1
              61352 Bad Homburg
              Germany
Internet:     www.fmc-ag.de
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------

Anleihe im Fokus

7,75% p.a. - Rendite aus Familienhand

– Zeichnungsstart: 23. Mai – Börse Frankfurt
– Zeichnung ab 1.000 Euro
– Laufzeit 5 Jahre
– WKN: A1TNA7
– 100% Rückzahlungskurs

GBC-Fokusbox

Syzygy AG: Aktie kaufen

Die nach den ersten drei Monaten des laufenden Jahres von Syzygy präsentierten Zahlen liegen im Rahmen unserer Erwartungen. Angesichts unserer unveränderten Prognosen behalten wir das bisherige Kursziel von 5 € bei und erneuern das Rating KAUFEN.

Aktuelle Research-Studie

Orad Hi-Tec Systems Ltd

Original-Research: Orad Hi Tec Systems (von VEM Aktienbank AG): Kaufen

21. Mai 2013